Table 9.
PHQ-9: 0–4 | PHQ-9: 5–9 | PHQ-9: 10–21 | p-value† | |
---|---|---|---|---|
UC | 19.87±5.47 | 25.41±7.64 | 34.53±8.50 | <0.001* |
CD | 19.01±4.57 | 24.00±5.18 | 30.21±7.92 | <0.001* |
| ||||
HADS-D: 0–7 | HADS-D: 8–10 | HADS-D: 11–21 | p-value† | |
| ||||
UC | 20.11±5.54 | 28.50±7.87 | 33.68±8.34 | <0.001* |
CD | 20.40±5.39 | 26.38±6.80 | 28.90±8.30 | <0.001* |
| ||||
HADS-A: 0–7 | HADS-A: 8–10 | HADS-A: 11–21 | p-value† | |
| ||||
UC | 19.91±4.79 | 31.48±6.83 | 37.50±7.84 | <0.001* |
CD | 20.44±4.58 | 30.12±6.03 | 39.63±6.97 | <0.001* |
p<0.05,
adjusting for other significant variables (UC: disease activity, CD: alcohol use, marital status, employment status, income) in generalized linear model.
IBD: inflammatory bowel disease, UC: ulcerative colitis, CD: Crohn’s disease, AT&T scale: Anxious Thoughts and Tendencies scale, PHQ-9: Patient Health Questionnaire-9, HADS: Hospital and Anxiety Depression Scale